0000912057-01-535226.txt : 20011019
0000912057-01-535226.hdr.sgml : 20011019
ACCESSION NUMBER: 0000912057-01-535226
CONFORMED SUBMISSION TYPE: RW
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20011012
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENZYME CORP
CENTRAL INDEX KEY: 0000732485
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061047163
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: RW
SEC ACT:
SEC FILE NUMBER: 333-52094
FILM NUMBER: 1757661
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQ
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6172527500
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
RW
1
a2060911zrw.txt
RW
GENZYME CORPORATION
ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
October 12, 2001
BY EDGAR
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn: Kevin Hands
Re: Genzyme Corporation
Registration Statement on Form S-3
(Registration No. 333-52094)
Dear Sir:
In accordance with Rule 477 promulgated under the Securities Act of
1933, as amended, Genzyme Corporation hereby withdraws the Registration
Statement on Form S-3 (Registration No. 333-52094) initially filed with the
Securities and Exchange Commission on December 18, 2000. Genzyme Corporation is
withdrawing the Registration Statement because it will not conduct the offering
of shares of Genzyme Biosurgery Division common stock contemplated in the
Registration Statement. None of the shares of Genzyme Biosurgery Division common
stock that were registered pursuant to the Registration Statement have been
issued or sold.
If you have any questions with respect to this letter, please call Paul
M. Kinsella of the law firm of Palmer & Dodge LLP at (617) 573-0513.
Sincerely,
GENZYME CORPORATION
By: /s/ Michael S. Wyzga
---------------------------------
Michael S. Wyzga
Senior Vice President, Finance
and Chief Financial Officer